Retractable Technologies ... (RVP)
Company Description
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.
It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network.
Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Country | United States |
IPO Date | May 4, 2001 |
Industry | Medical - Instruments & Supplies |
Sector | Healthcare |
Employees | 221 |
CEO | Thomas J. Shaw |
Advertisement
Contact Details
Address: 511 Lobo Lane Little Elm, Texas United States | |
Website | https://www.retractable.com |
Stock Details
Ticker Symbol | RVP |
Exchange | AMEX |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000946563 |
CUSIP Number | 76129W105 |
ISIN Number | US76129W1053 |
Employer ID | 75-2599762 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Thomas J. Shaw | Founder, Chairman, President & Chief Executive Officer |
John W. Fort III | Vice President, Chief Financial Officer, Principal Accounting Officer,Treasurer & Director |
Lawrence G. Salerno | Director of Operations |
Michele M. Larios Esq. | Vice President, General Counsel & Secretary |
Russell B. Kuhlman | Vice President of Sales Development |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 23, 2025 | 4 | Filing |
Apr 17, 2025 | 4 | Filing |
Apr 14, 2025 | 4 | Filing |
Apr 11, 2025 | 8-K | Current Report |
Apr 10, 2025 | 4 | Filing |
Apr 08, 2025 | 4 | Filing |
Apr 04, 2025 | 4 | Filing |
Apr 01, 2025 | 4 | Filing |
Mar 28, 2025 | 8-K | Current Report |
Mar 28, 2025 | 10-K | Annual Report |